TY - JOUR
T1 - Evolution of screen-detected small (6-9 mm) polyps after a 3-year surveillance interval
T2 - Assessment of growth with CT colonography compared with histopathology
AU - Nolthenius, Charlotte J.Tutein
AU - Boellaard, Thierry N.
AU - De Haan, Margriet C.
AU - Nio, C. Yung
AU - Thomeer, Maarten G.J.
AU - Bipat, Shandra
AU - Montauban Van Swijndregt, Alexander D.
AU - Van De Vijver, Marc J.
AU - Biermann, Katharina
AU - Kuipers, Ernst J.
AU - Dekker, Evelien
AU - Stoker, Jaap
N1 - Publisher Copyright:
© 2015 by the American College of Gastroenterology.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Objectives:Volumetric growth assessment has been proposed for predicting advanced histology at surveillance computed tomography (CT) colonography (CTC). We examined whether is it possible to predict which small (6-9 mm) polyps are likely to become advanced adenomas at surveillance by assessing volumetric growth.Methods:In an invitational population-based CTC screening trial, 93 participants were diagnosed with one or two 6-9 mm polyps as the largest lesion(s). They were offered a 3-year surveillance CTC. Participants in whom surveillance CTC showed lesion(s) of ≥6 mm were offered colonoscopy. Volumetric measurements were performed on index and surveillance CTC, and polyps were classified into growth categories according to ±30% volumetric change (>30% growth as progression, 30% growth to 30% decrease as stable, and >30% decrease as regression). Polyp growth was related to histopathology.Results:Between July 2012 and May 2014, 70 patients underwent surveillance CTC after a mean surveillance interval of 3.3 years (s.d. 0.3; range 3.0-4.6 years). In all, 33 (35%) of 95 polyps progressed, 36 (38%) remained stable, and 26 (27%) regressed, including an apparent resolution in 13 (14%) polyps. In 68 (83%) of the 82 polyps at surveillance, histopathology was obtained; 15 (47%) of 32 progressing polyps were advanced adenomas, 6 (21%) of 28 stable polyps, and none of the regressing polyps.Conclusions:The majority of 6-9 mm polyps will not progress to advanced neoplasia within 3 years. Those that do progress to advanced status can in particular be found among the lesions that increased in size on surveillance CTC.
AB - Objectives:Volumetric growth assessment has been proposed for predicting advanced histology at surveillance computed tomography (CT) colonography (CTC). We examined whether is it possible to predict which small (6-9 mm) polyps are likely to become advanced adenomas at surveillance by assessing volumetric growth.Methods:In an invitational population-based CTC screening trial, 93 participants were diagnosed with one or two 6-9 mm polyps as the largest lesion(s). They were offered a 3-year surveillance CTC. Participants in whom surveillance CTC showed lesion(s) of ≥6 mm were offered colonoscopy. Volumetric measurements were performed on index and surveillance CTC, and polyps were classified into growth categories according to ±30% volumetric change (>30% growth as progression, 30% growth to 30% decrease as stable, and >30% decrease as regression). Polyp growth was related to histopathology.Results:Between July 2012 and May 2014, 70 patients underwent surveillance CTC after a mean surveillance interval of 3.3 years (s.d. 0.3; range 3.0-4.6 years). In all, 33 (35%) of 95 polyps progressed, 36 (38%) remained stable, and 26 (27%) regressed, including an apparent resolution in 13 (14%) polyps. In 68 (83%) of the 82 polyps at surveillance, histopathology was obtained; 15 (47%) of 32 progressing polyps were advanced adenomas, 6 (21%) of 28 stable polyps, and none of the regressing polyps.Conclusions:The majority of 6-9 mm polyps will not progress to advanced neoplasia within 3 years. Those that do progress to advanced status can in particular be found among the lesions that increased in size on surveillance CTC.
UR - http://www.scopus.com/inward/record.url?scp=84951569175&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951569175&partnerID=8YFLogxK
U2 - 10.1038/ajg.2015.340
DO - 10.1038/ajg.2015.340
M3 - Article
C2 - 26482858
AN - SCOPUS:84951569175
SN - 0002-9270
VL - 110
SP - 1682
EP - 1690
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 12
ER -